BALAXI PHARMACEUTICALS LIMITED — Others, 30-05-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to consider the financial results for the quarter and half-year. This review offers key insights into recent operational performance and profitability, which will help investors gauge the company’s growth trajectory and efficiency. The announced results are likely to impact market sentiment and shareholder confidence in its future prospects.